Clinical trials
Melanoma trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 5 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 8 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 9 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
| Unknown status | 17 |
| Active, not recruiting | 7 |
| Terminated | 6 |
| Recruiting | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biocad | 11 |
| Bristol-Myers Squibb | 11 |
| Hoffmann-La Roche | 7 |
| GlaxoSmithKline | 5 |
| N.N. Petrov National Medical Research Center of Oncology | 5 |
| Novartis Pharmaceuticals | 5 |
| MelanomaPRO, Russia | 4 |
| Pfizer | 4 |
| Amgen | 3 |
| Russian Academy of Medical Sciences | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 79 |
| Neoplasms | 16 |
| Skin Neoplasms | 7 |
| Lung Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Carcinoma, Renal Cell | 5 |
| Sarcoma | 4 |
| Breast Neoplasms | 3 |
| Colorectal Neoplasms | 3 |
| Kidney Neoplasms | 3 |
Trials
Showing 76 to 79 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.